In a bid to promote the accessibility and affordability of essential medications for Nigerian consumers, the Federal Competition and Consumer Protection Commission (FCCPC) has initiated an investigation into the escalating costs and price disparities of blood pressure (BP) and diabetic drugs across various markets in the country.
Speaking at a stakeholder engagement session held in Abuja, the Executive Vice Chairman of the FCCPC, Mr. Tunji Bello, emphasized that the inquiry aims to enhance healthcare delivery and ensure affordable medication for all Nigerians. Represented by the Director of Surveillance and Investigations at the Commission, Mrs. Boladale Adeyinka, Mr. Bello noted that the initiative also seeks to safeguard consumers from exploitation and uphold their rights and well-being.